Cargando...
Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease
OBJECTIVE: Thyroid eye disease (TED) is generally treated with oral corticosteroid therapy. A steroid sparing drug could be a useful adjunct. We reviewed our experience with methotrexate as a corticosteroid sparing agent to treat TED. METHODS: Retrospective chart review from two eye inflammation cli...
Gardado en:
| Publicado en: | J Clin Exp Ophthalmol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4718577/ https://ncbi.nlm.nih.gov/pubmed/26807304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-9570.1000422 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|